logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Ó

Óscar Fernández

universidad de malaga
H指数:49
被引数:8,625

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated Inflammatory, Thrombo-Inflammatory, Redox and Soluble IFNAR2 Profiling During Hospitalization for COVID-19: An Exploratory Observational Cohort Study

住院期间COVID-19的整合炎症、血栓-炎症、氧化还原和可溶性IFNAR2谱分析：一项探索性观察队列研究

Journal of Clinical Medicine
IF2.9
2026-09-010
OA
Álvaro Martínez Mesa; Eva Cabrera César; María García-Fernandez; Pablo Zamorano-González; María Mercedes Segura Romero; Javier López García; Elisa Martín-Montañez; Óscar Fernández; Jose Luis Velasco Garrido
Economic burden of heart failure in Europe: A systematic review of costs and cost-effectiveness

欧洲心力衰竭的经济负担：一项关于成本和成本效益的系统综述

ESC HEART FAILURE
IF3.7
2025-11-010
OAAI
Darba, Josep; Ascanio, Meritxell; Rodriguez, Antonio; Charman, Sarah J.; Okwose, Nduka C.; Stefanetti, Renae J.; Groenewegen, Amy; Del Franco, Annamaria; Tafelmeier, Maria; Preveden, Andrej; Fuller, Amy S.; Bano, Fatima; Sinclair, David R.; Edwards, Duncan; Nelissen, Anne P.; Malitas, Petros N.; Zisaki, Aikaterini; Bosnic, Zoran; Vracar, Petar; Fornaro, Alessandra; Barlocco, Fausto; Fotiadis, Dimitris; Banerjee, Prithwish; MacGowan, Guy A.; Fernandez, Oscar; Zamorano, Jose Luis; Jimenez-blanco Bravo, Marta; Maier, Lars S.; Olivotto, Iacopo; Milli, Massimo; Rutten, Frans H.; Mant, Jonathan; Velicki, Lazar; Seferovic, Petar M.; Filipovic, Nenad; Jakovljevic, Djordje G.; STRATIFYHF investigators
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
FRONTIERS IN IMMUNOLOGY
IF5.9
2021-12-167
OAAI
Aliaga-Gaspar, Pablo; Hurtado-Guerrero, Isaac; Ciano-Petersen, Nicolas Lundahl; Urbaneja, Patricia; Brichette-Mieg, Isabel; Reyes, Virginia; Rodriguez-Bada, Jose Luis; Alvarez-Lafuente, Roberto; Arroyo, Rafael; Quintana, Ester; Ramio-Torrenta, Lluis; Alonso, Ana; Leyva, Laura; Fernandez, Oscar; Oliver-Martos, Begona
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
MULTIPLE SCLEROSIS JOURNAL
IF5
2021-12-0913
OAAI
Coles, Alasdair J.; Jones, Joanne L.; Vermersch, Patrick; Traboulsee, Anthony; Bass, Ann D.; Boster, Aaron; Chan, Andrew; Comi, Giancarlo; Fernandez, Oscar; Giovannoni, Gavin; Kubala Havrdova, Eva; LaGanke, Christopher; Montalban, Xavier; Oreja-Guevara, Celia; Piehl, Fredrik; Wiendl, Heinz; Ziemssen, Tjalf
Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study)

一组原发性进行性多发性硬化症患者的疾病活动，认知，情绪，污名和就业结果的短期数据 (UPPMS研究)

MULTIPLE SCLEROSIS AND RELATED DISORDERS
IF2.9
2021-05-019
PREAI
Perez-Miralles, Francisco; Prefasi, Daniel; Garcia-Merino, Antonio; Ramon Ara, Jose; Izquierdo, Guillermo; Meca-Lallana, Virginia; Gascon-Gimenez, Francisco; Luisa Martinez-Gines, Maria; Ramio-Torrenta, Lluis; Costa-Frossard, Lucienne; Fernandez, Oscar; Moreno-Garcia, Sara; Medrano, Nicolas; Maurino, Jorge; Casanova, Bonaventura
Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
SCIENTIFIC REPORTS
IF3.9
2020-08-2813
OAAI
Inmaculada Dominguez-Mozo, Maria; Perez-Perez, Silvia; Maria Villar, Luisa; Oliver-Martos, Begona; Villarrubia, Noelia; Matesanz, Fuencisla; Costa-Frossard, Lucienne; Jesus Pinto-Medel, Maria; Isabel Garcia-Sanchez, Maria; Ortega-Madueno, Isabel; Lopez-Lozano, Lorena; Garcia-Martinez, Angel; Izquierdo, Guillermo; Fernandez, Oscar; Carlos Alvarez-Cermeno, Jose; Arroyo, Rafael; Alvarez-Lafuente, Roberto
Targeted resequencing reveals rare variants enrichment in multiple sclerosis susceptibility genes
HUMAN MUTATION
IF3.7
2020-04-011
OAAI
Gil-Varea, Elia; Spataro, Nino; Villar, Luisa Maria; Tejeda-Velarde, Amalia; Midaglia, Luciana; Matesanz, Fuencisla; Malhotra, Sunny; Eixarch, Herena; Patsopoulos, Nikolaos; Fernandez, Oscar; Oliver-Martos, Begona; Saiz, Albert; Llufriu, Sara; Ramio-Torrenta, Lluis; Quintana, Ester; Izquierdo, Guillermo; Alcina, Antonio; Bosch, Elena; Navarro, Arcadi; Montalban, Xavier; Comabella, Manuel
A New Risk Variant for Multiple Sclerosis at 11q23.3 Locus Is Associated with Expansion of CXCR5+ Circulating Regulatory T Cells
JOURNAL OF CLINICAL MEDICINE
IF2.9
2020-02-266
OAAI
Gil-Varea, Elia; Fedetz, Maria; Eixarch, Herena; Spataro, Nino; Villar, Luisa Maria; Urcelay, Elena; Saiz, Albert; Fernandez, Oscar; Leyva, Laura; Ramio-Torrenta, Lluis; Vandenbroeck, Koen; Otaegui, David; Castillo-Trivino, Tamara; Izquierdo, Guillermo; Malhotra, Sunny; Bosch, Elena; Navarro, Arcadi; Alcina, Antonio; Montalban, Xavier; Matesanz, Fuencisla; Comabella, Manuel
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies
MULTIPLE SCLEROSIS JOURNAL
IF5
2019-11-2519
OAAI
Comi, Giancarlo; Alroughani, Raed; Boster, Aaron L.; Bass, Ann D.; Berkovich, Regina; Fernandez, Oscar; Kim, Ho Jin; Limmroth, Volker; Lycke, Jan; Macdonell, Richard A. L.; Sharrack, Basil; Singer, Barry A.; Vermersch, Patrick; Wiendl, Heinz; Ziemssen, Tjalf; Jacobs, Alan; Daizadeh, Nadia; Rodriguez, Claudio E.; Traboulsee, Anthony
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies

阿仑单抗在1和2疗程之间复发的复发缓解型多发性硬化症患者中6年以上的疗效: CARE-MS研究的事后分析

MULTIPLE SCLEROSIS JOURNAL
IF5
2019-11-0117
OAAI
Van Wijmeersch, Bart; Singer, Barry A.; Boster, Aaron; Broadley, Simon; Fernandez, Oscar; Freedman, Mark S.; Izquierdo, Guillermo; Lycke, Jan; Pozzilli, Carlo; Sharrack, Basil; Steingo, Brian; Wiendl, Heinz; Wray, Sibyl; Ziemssen, Tjalf; Chung, Luke; Margolin, David H.; Thangavelu, Karthinathan; Vermersch, Patrick
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis

在多发性硬化症的小鼠模型中，干扰素-β 治疗后，髓源性抑制细胞的存在和抑制活性得到增强

NEUROBIOLOGY OF DISEASE
IF5.6
2019-07-0132
OAAI
Melero-Jerez, Carolina; Suardiaz, Margarita; Lebron-Galan, Rafael; Marin-Banasco, Carmen; Oliver-Martos, Begona; Machin-Diaz, Isabel; Fernandez, Oscar; de Castro, Fernando; Clemente, Diego

研究方向

暂未获取到该数据
L
Laura Leyva
H 指数:32论文数:108被引数:3,185
X
Xavier Montalbán
H 指数:126论文数:1,357被引数:8.9万
F
Fuencisla Matesanz
H 指数:34论文数:99被引数:2,926
G
Guillermo Izquierdo
H 指数:57论文数:324被引数:1.4万
M
Manuel Comabella
H 指数:68论文数:383被引数:2.3万
B
Begoña Oliver‐Martos
H 指数:21论文数:95被引数:1,651
E
Elena Urcelay
H 指数:46论文数:239被引数:8,393
A
Antonio Alcina
H 指数:34论文数:94被引数:2,948
K
Koen Vandenbroeck
H 指数:39论文数:160被引数:4,864
M
María Jesús Pinto-Medel
H 指数:15论文数:32被引数:599